18f-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor Glycolysis

Molecular Therapy - Nucleic Acids - United States
doi 10.1038/mtna.2016.72
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparative Diagnostic Accuracy of 18f-FDG PET/CT for Breast Cancer Recurrence

Breast Cancer: Targets and Therapy
Oncology
2017English

18f-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Mixed Response on Regorafenib Treatment for GIST (Gastro-Intestinal Stromal Tumor) According to 18f–fdg-Pet/Ct

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Is 18f-FDG PET/CT Useful for Diagnosing Relapsing Polychondritis With Airway Involvement and Monitoring Response to Steroid-Based Therapy?

Arthritis Research & Therapy
2019English

18f-FDG PET in Detecting Primary Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18f-FDG PET/CT Using PERCIST

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Simultaneous Breast Cancer and DLBCL Lymphoma — Role of PET/CT Examination With 18f-FDG and 18f-Fes

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2018English

Assessment of Interobserver Reproducibility in Quantitative 18f-FDG PET and CT Measurements of Tumor Response to Therapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy